Research in the Quadri Lab

Dr. Quadri's research integrates cutting-edge diagnostics, digital health innovation, and medical education transformation to address critical gaps in healthcare delivery.

A Vision for Transformative Healthcare

Dr. Quadri is establishing the nation's first comprehensive research institute focused on the critical intersection of sleep disorders and metabolic health -two interconnected epidemics affecting over 100 million Americans.

Mission

Accelerate diagnostic innovation and therapeutic breakthroughs at the nexus of sleep medicine and metabolic dysfunction through integrated research, clinical translation, and public health initiatives.

Impact

Transform care for millions suffering from OSA, diabetes, obesity, and related conditions while preventing thousands of accidents and saving billions in healthcare costs through early detection and intervention.

Core Programs

• Diagnostic Innovation Lab: Breath biomarkers, EV-based diagnostics, Al-powered screening
• Clinical Translation Core: Fast-track promising discoveries from bench to bedside
• Public Health & Safety Initiative: Drowsy driving prevention, occupational safety programs
• Digital Health Innovation: Virtual sleep clinics, remote monitoring, predictive analytics

Sleep & Public Safety Research

Leading the Real-Time Indication of Sleepiness Evaluation (RISE) study to develop non-invasive diagnostic tools using extracellular vesicle (EV)-associated microRNA analysis in exhaled breath condensate. This breakthrough technology aims to identify high-risk drivers and reduce healthcare costs by minimizing reliance on traditional sleep studies.

Diagnostic Innovation

Diagnostic fingerprints and biomarkers (digital, phenotypic & genetic) for sleep disorders and metabolic syndrome.

Pioneering breath-based biomarker discovery for early detection of sleep apnea and metabolic syndrome. Research includes fractional exhaled nitric oxide

(FENO) as a potential biomarker and development of portable diagnostic devices for point-of-care testing.

AI-Powered Medical Education Innovation

Developing next-generation educational platforms that blend artificial intelligence, mixed reality, and clinical strategy. Creating ML-powered virtual patients and holographic anatomy modules to prepare physicians for Al-integrated healthcare. Collaborating with pharmacy schools including Binghamton University to advance interdisciplinary education.

Healthcare Strategy & Innovation

Translating research insights into enterprise-wide strategies for value-based care, digital health transformation, and integrated care delivery models aligned with the Triple Aim of healthcare improvement.

Completed Clinical Studies

Dr. Mohammed Quadri has led and contributed to numerous clinical research studies aimed at improving patient outcomes, advancing care models, and integrating innovation into clinical practice. Key studies include:

2016 – 2017

• The PICK Study | Hackensack University Medical Center
  
  The PICK Study - Parkinsons Disease Inpatient Clinical Knowledge and Management.
  
  Focused on improving inpatient Parkinson’s Disease management. The program reduced medication errors and complications by enhancing clinician knowledge and protocol adherence.

2015 – 2016

• CAPE Study | Hackensack University Medical Center
  
  CAPE study: CAM (Confusion Assessment Method) compliance in Adult PatiEnts Investigated compliance with Confusion Assessment Method (CAM) screening within 12 hours of hospital admission and its correlation with patient outcomes such as mortality, readmission rates, and length of stay.

2015 – 2017

• IMACH Study | Lowenstein Foundation
  
  IMACH Study-Impact of a Multidisciplinary Approach in a Congestive Heart Failure Unit on Patient Outcomes.
  
  Studied the effectiveness of a multidisciplinary approach in a heart failure unit. Findings supported that dedicated care teams improved survival and reduced readmissions.
  
  
• ADOPT Study | Hackensack University Medical Center
  Accurate Display Of Postpartum Hemorrhage Using Triton (ADOPT)
  
  Compared estimated blood loss in vaginal deliveries with quantitative loss measured by the Triton™ system, exploring predictors of postpartum hemorrhage and transfusions.
  
  
• Sound Environment on Patient Outcomes | Hackensack University Medical Center
  
  Effect of the Sound Environment on Patient Outcomes and Staff Performance in the Inpatient Hospital Setting
  
  Analyzed how noise levels in hospital units impact patient outcomes like delirium, cognitive dysfunction, and length of stay.

2015 – 2018

• PAUSE Trial | Hackensack University Medical Center
  
  PAUSE Trial: The Peripheral Access Utilizing Sonographic Evaluation Study.
  
  Assessed ultrasound-guided IV access in critically ill patients with difficult venous access. Findings indicated reduced central line placements and improved safety outcomes compared to traditional methods.

2014 – 2015

• The IMPROVE Study | Omnicell, Inc.
  
  The IMPROVE Study: Impact of a Regulated ADC System On Medication Distribution and Administration Variables.
  
  Evaluated the impact of a regulated Automated Dispensing Cabinet (ADC) system on medication administration and nurse satisfaction. The system enhanced timely medication delivery and reduced errors.
  Role: Co-Investigator
  
  
• EMERALD | Hackensack University Medical Center
  
  EMERALD: Evaluating the impact of pharmacist collected medication reconciliation on the accuracy of the discharge medication reconciliation document
  
  Assessed how pharmacist-led medication reconciliation in the Emergency Department improves the accuracy of discharge medication records.
  
  
• NIHSS Study | Hackensack University Medical Center
  
  NIH Stroke Scale as an Early Predictor of Discharge Disposition
  
  Explored how National Institute of Health Stroke Scale (NIHSS) scores within 48 hours predict stroke patient discharge outcomes, aiming to support early care planning.